Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. COF
6. SMCI
7. GOOGL
8. RTX
9. TSLA
10. BRZE

Go back to Bristol-Myers Squibb Announces Time Change for Q4 Earnings Results Conference Call

BMO Capital Reiterates Outperform on Bristol-Myers Squibb (BMY)

January 25, 2019 8:45 AM EST

BMO Capital analyst, Alex Arfaei, reiterated an Outperform rating and $60.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY) following the company's 4Q earnings report. Arfaei remains comfortable with Bristol's independent business: from 2018 to 2022, BMO Capital forecasts revenue and EPS CAGRs of 5% and 8%,... More